Circulation. Arrhythmia and electrophysiology

Circulation. Arrhythmia and electrophysiology
Audio Summaries

Every issue of Circulation. Arrhythmia and electrophysiology moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.

48 audio summariesNLM Catalog

Recent summaries

The latest articles summarized from Circulation. Arrhythmia and electrophysiology.

Dynamic Risk Assessment of Severe Ventricular Arrhythmia in Patients With Implantable Defibrillators and Reduced Left Ventricular Ejection Fraction.

Nov 20, 2026

This study asks whether dynamic changes in intracardiac electrograms and surface ECG, reflecting heart failure decompensation, can predict imminent polymorphic VT or VF in patients with ICDs and HFrEF better than static clinical risk factors. Using a pig HFrEF model to identify relevant electrical markers (QRS prolongation and reduced R-wave amplitude), the authors trained a convolutional neural network on data from 5,089 ICD patients and externally validated it in 2,040 patients. The model, which analyzed trends in R-wave amplitude, QRS duration, and PVC burden, achieved AUCs of 0.725 in external validation and significantly outperformed static clinical risk assessment (AUC 0.617).

Incidence, Risk Factors and Natural History of Atrial Arrhythmias in Patients With Systemic Right Ventricle.

Nov 19, 2026

This study examined how often atrial fibrillation and atrial flutter occur in adults with a systemic right ventricle (congenitally corrected transposition or d-TGA after atrial switch) and what factors predict them. In a Mayo Clinic cohort of 447 patients followed for a median of 11 years, 25% already had atrial arrhythmias at first visit and 37% of the remainder developed new ones, with older age, d-TGA, and longer QRS duration independently associated with risk. Although atrial arrhythmias were linked to heart failure hospitalization and frequently recurred after treatment, they were not an independent predictor of mortality, supporting close surveillance and early intervention in this population.

Myocardial Hmgcs2-Driven Ketogenesis Promotes Atrial Fibrillation in Diabetes.

Nov 18, 2026

In patients and mice with type 2 diabetes, the authors asked whether elevated cardiac expression of the ketogenic enzyme Hmgcs2 contributes to atrial fibrillation (AF), independent of the liver's known role in producing circulating ketones. They found the heart becomes a major ketogenic organ in diabetes, where Hmgcs2-driven ketogenesis depletes energy reserves, increases oxidative stress and mitochondrial injury, and promotes AF and diastolic dysfunction, partly by degrading the ketolysis enzyme Oxct1 through β-hydroxybutyrylation. Cardiomyocyte-specific Hmgcs2 knockdown reduced diabetes-associated AF in mice, suggesting cardiac Hmgcs2 as a potential therapeutic target.

Cardiac Electrophysiological Impact of Sodium Glucose Cotransporter 2 Inhibitors: A Comprehensive Review.

Oct 28, 2026

This review asks whether SGLT2 inhibitors, beyond their glycemic and heart failure benefits, meaningfully affect cardiac autonomic function, arrhythmia risk, and related microRNA signaling. The authors synthesize clinical trials, meta-analyses, and preclinical studies, finding evidence of sympathoinhibition, modest reductions in atrial fibrillation/flutter and possibly sudden cardiac death, and anti-arrhythmic mechanisms such as NHE and late sodium current inhibition. They also report that SGLT2 inhibitors modulate microRNAs (e.g., miR-21, miR-29, miR-30, miR-34a, miR-92) that may underlie these effects, but they conclude that dedicated trials are needed to establish causality and dose-dependence.

Multichannel Dysfunction Associated With a Dominant-Negative KCNH2 Missense Variant, p.G604S, Results in Action Potential Duration Prolongation and Early Afterdepolarizations in a Patient-Specific, Reengineered Cardiomyocyte Model of Type 2 Long-QT Syndrome.

Oct 12, 2026

This study used patient-derived iPSC-cardiomyocytes carrying the dominant-negative KCNH2-G604S variant and an isogenic control to ask whether secondary inward-current dysfunction (sodium and L-type calcium) amplifies the potassium-channel loss underlying type 2 long-QT syndrome. The KCNH2-G604S cells showed severe IKr loss, marked action potential prolongation, and early afterdepolarizations, with increased persistent L-type calcium current identified as the key driver. Computational modeling supported this, showing that persistent calcium current synergistically extended action potential duration beyond the effects of IKr loss alone.

Value of Left Ventricular Low Voltage Area and Ejection Fraction in Predicting End-Stage Heart Failure Outcomes After Ventricular Tachycardia Ablation in Patients With Non-Ischemic Cardiomyopathy.

Oct 8, 2026

This study asked whether left ventricular unipolar and bipolar low-voltage areas (LVAs) during endocardial mapping predict end-stage heart failure outcomes (HF death, LV assist device, or transplant) in 111 patients with nonischemic cardiomyopathy undergoing ventricular tachycardia ablation. Over a median of 28 months, unipolar LVA and lower LVEF were independent predictors of these outcomes, whereas bipolar LVA was not. A simple 3-point score combining unipolar LVA extent and LVEF ≤25% identified high-risk patients with 82% sensitivity and 77% specificity.

Serial Artificial Intelligence ECG-Derived Atrial Fibrillation Probability and Recurrence Risk After Pulsed Field Ablation.

Oct 8, 2026

This study asked whether a sinus-rhythm AI-enabled ECG score for atrial fibrillation, both at baseline and in its early change after ablation, predicts recurrence after pulsed field ablation. In 1,052 Mayo Clinic patients, a higher baseline score was independently associated with recurrence, and attenuated early recovery (higher 90-day recovery index) was the most robust postablation predictor, modestly improving discrimination beyond clinical covariates (C-statistic 0.63 to 0.67). The authors conclude these ECG-based measures may aid risk stratification, pending prospective validation.

Role of Lifestyle and Risk Factor Modification Clinics in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Oct 7, 2026

This systematic review and meta-analysis of 11 randomized trials (3,364 patients with atrial fibrillation) asked whether lifestyle and risk factor modification (LRFM) clinics improve outcomes compared with usual care. LRFM clinics significantly reduced atrial arrhythmia recurrence after catheter ablation (OR 0.34), reduced AF-related hospitalization, and improved quality of life, while showing no clear difference in heart failure hospitalization, cardiovascular death, or stroke/TIA. The findings support a comprehensive, multidisciplinary lifestyle-focused model of AF care, though the benefit on hard clinical endpoints beyond hospitalization remains unproven.

NIMA-Related Kinase-7 Activates Atrial Cardiomyocyte NLRP3 Inflammasome and Associates With Occurrence of Postoperative Atrial Fibrillation.

Oct 7, 2026

NEK7 is a kinase known to drive NLRP3 inflammasome assembly in immune cells, but its role in atrial cardiomyocytes and atrial arrhythmias was unknown. This study asked whether NEK7 is required for NLRP3 inflammasome activation in atrial cardiomyocytes and whether it is linked to postoperative atrial fibrillation (poAF), a common complication of open-heart surgery driven by NLRP3 signaling. The findings address whether NEK7 serves as an upstream regulator of proarrhythmic inflammation in the atria of poAF-prone patients.

Reclassifying Single Lead Sinus Rhythm ECGs for Improved AF Recurrence Detection With Deep Learning.

Oct 7, 2026

Atrial fibrillation often recurs after catheter ablation, and existing approaches struggle to define effective observation and prediction windows for recurrence. The authors asked whether a deep learning model could reclassify single-lead sinus rhythm ECGs from handheld devices by their proximity (within ±3 days) to AF events, using 558 participants. The model achieved an AUC of 0.86, outperforming a clinical-feature Random Forest benchmark (AUC 0.71), suggesting that brief sinus rhythm strips can indicate short-term AF risk.

Listen to Circulation. Arrhythmia and electrophysiology

14-day free trial. Every new article, summarized in ~3 minutes.